"3-Day Surprise Question" to predict prognosis of advanced cancer patients with impending death: Multicenter prospective observational study

Cancer Med. 2021 Feb;10(3):1018-1026. doi: 10.1002/cam4.3689. Epub 2020 Dec 21.

Abstract

Background: The study aimed to clarify the efficacy of the "3-Day Surprise Question (3DSQ)" in predicting the prognosis for advanced cancer patients with impending death.

Patients and methods: This study was a part of multicenter prospective observational study which investigated the dying process in advanced cancer patients in Japan. For patients with a Palliative Performance Scale ≤20, the 3DSQ "Would I be surprised if this patient died in the next 3 days?" was answered by their physicians. In addition to the sensitivity and specificity of the 3DSQ, the characteristics of patients who survived longer than expected were examined via multivariate analysis.

Results: Among the 1896 patients enrolled, 1411 were evaluated. Among 1179 (83.6%) patients who were classified into the "Not surprised" group, 636 patients died within 3 days. Among 232 (16.4%) patients of "Yes surprised" group, 194 patients lived longer than 3 days. The sensitivity, specificity, positive predictive value, and negative predictive value of the 3DSQ were 94.3% (95% confidence interval [CI]: 92.7% to 95.8%), 26.3% (95% CI: 24.8% to 27.6%), 53.9% (95% CI: 53.0% to 54.7%), and 83.6% (95% CI: 78.7% to 87.7%), respectively. Multivariate analysis showed palpable radial artery, absent respiration with mandibular movement, SpO2 ≥ 90%, opioid administration, and no continuous deep sedation as characteristics of patients who lived longer than expected.

Conclusions: The 3-Day Surprise Question can be a useful screening tool to identify advanced cancer patients with impending death.

Keywords: advanced cancer; end-of-life care; impending death; predict prognosis; surprise question.

Publication types

  • Multicenter Study
  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Female
  • Follow-Up Studies
  • Humans
  • Japan
  • Male
  • Middle Aged
  • Neoplasms / mortality*
  • Neoplasms / psychology*
  • Palliative Care / psychology*
  • Physicians / statistics & numerical data*
  • Predictive Value of Tests
  • Prognosis
  • Prospective Studies
  • Surveys and Questionnaires
  • Survival Rate